17 Aug, 2023
A biomaterial is a substance designed to interact with biological systems for therapeutic (to treat, enhance, restore, or replace a body tissue function) or diagnostic medical purposes. Biomaterials are synthetic or natural compounds synthesized artificially and used in the medical and technological sectors to improve the function of damaged tissues or organs. Biomaterials can be created using metals, ceramics, plastic, glass, and biological cells and tissue.
Biomaterials can be re-engineered for biomedical products and devices into molded or machined elements, coatings, fibers, films, foams, and textiles. They are frequently biodegradable, and some are bioabsorbable, meaning they are progressively eliminated from the body once their purpose has been fulfilled. These biomaterials collaborate with biological systems to treat heart, mouth, joint, and nervous disorders.
Rising Demand as a Consequence of Accidental Injuries and Chronic Conditions Drives the Global Market
The World Health Organization stated that rising healthcare expenditures have improved global healthcare infrastructure. Approximately 30 percent of global fatalities are caused by cardiovascular disease. Even in developing economies, lifestyle disorders, and chronic diseases have increased due to lifestyle and economic development changes. With the advancement of biomaterials research, materials are now safer, more accessible, and more dependable.
In addition, implants and prosthetics used in accidental surgeries and injuries are now more affordable and accessible due to rising healthcare costs. Increasing rates of incidental injuries, which account for most organ replacement procedures, are likely to offer excellent growth prospects for this industry. Therefore, the market for biomaterial implants is anticipated to expand over the forecast period.
Advancements in Biomaterials Technologies Creates Tremendous Opportunities
The demand for novel biomaterials has increased due to their increasing use for replacing and repairing tissues such as bones, teeth, and other damaged tissues and organs over the past few years. Bio-based materials are used in various healthcare settings, including sandworm glue as a biocompatible surgical adhesive and polylactic acid as a high-strength bone implant. Due to the accessibility of compatible biomaterials on the market and the expanding use of bioplastics because of their biocompatibility and biodegradability, they are also used in hip and knee surgeries.
Businesses are critical in addressing this challenge by developing new solutions and instruments. Galatea Surgical, a subsidiary of Tepha Inc., launched GalaSHAPE 3D surgical scaffold for aesthetic plastic surgery procedures in March 2017. Moreover, numerous research institutes and centers in the United Kingdom are developing innovative biomaterial products and services. Such universities include the University of Nottingham, the University of Cambridge, and Cranfield University. These factors provide opportunities for market expansion.
North America is the most significant global biomaterials market shareholder and is estimated to exhibit a CAGR of 15.5% during the forecast period. The high geriatric population, increasing incidence of trauma and number of complex surgeries, favorable reimbursement policies, and substantial government funding all contributed to the development of the North American region. The presence of established actors and their efforts to develop technologically advanced and safe biomaterials and devices contribute to the market expansion. In addition, the country's local presence of several key market players, such as Carpenter Technology Corporation, Inc. and Berkeley Advanced Biomaterials, Inc., drives technological advancements and market expansion. These companies are engaged in developing advanced biomaterials for medical procedures and practices. The increase in funding for biotechnology research also contributes to market expansion.
Europe is estimated to exhibit a CAGR of 15.1% over the forecast period. The development of novel biomaterials for use in wound healing, plastic surgery, tissue engineering, ophthalmology, and neurology, along with an increase in the number of conferences and research-related activities, have contributed to the expansion of this market. Increased government investments in the biomaterials sector, CMS reimbursements, and a rise in the geriatric population, one of the market's primary end consumers, also drive the market. In addition, the substantial market share of Germany's biomaterials market can be attributed to major actors' investments and innovations, well-established industrial infrastructure, and supportive government regulations. In the future, several German organizations are committed to delivering safer and more biocompatible biomaterials. Increasing biopharmaceutical manufacturing company investment is also a significant growth driver.